Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology...
Cancer
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
WESTLAKE VILLAGE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced...
Voting Rights and Shares Capital of the Company
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French...
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is...
Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
Clinical labs face critical operational challenges that impede productivity—more patient samples to test, staffing shortages, and more documentation requirements. The...
NextGen Healthcare Chosen by Kymera Independent Physicians to Expand Access to Critical Hematology and Oncology Care in Rural Areas
Award-winning EHR Software Enables More Time with Patients, Improved Quality Care, and Streamlined OperationsREMOTE-FIRST COMPANY/ROSWELL, N.M.--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc....
Halberd Corporation 2Q23 CEO Letter
JACKSON CENTER, PA / ACCESSWIRE / July 20, 2023 / Halberd Corporation (OTC PINK:HALB). During the second quarter 2023 Halberd...
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming...
Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
New data demonstrates that ART26.12 works by activating multiple receptors implicated in pain signaling and is able to broadly modify...
Zymeworks To Host Second Quarter 2023 Results Conference Call
VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional...
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants
Patients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials...
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML
Phase 2 Trials in Relapsed/Refractory and Frontline Settings Planned, APVO436 to be administered in Combination with Emerging Standard of CareNew...
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and...
Celularity Human Placental-Derived Advanced Biomaterials Demonstrate Superior Biocompatibility and Better Support Differentiated Cell Functions in Studies
Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human placental-derived biomaterials at ICBST23, the...
Cepham’s Prosprune Protects Men and Sustains the Environment in the Name of Prostate Health
Developing Prosprune® Recognizing the need for an alternative to the endangered Pygeum africanum, the research team at Cepham analyzed various...
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
Surrounded by world renowned universities and medical centers,Predictive Oncology is part of the next generation of Pittsburgh’s innovation ecosystem PITTSBURGH,...
Defence Successfully Completes the First Milestone of Its Collaboration Agreement with Orano
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
With a standard review, FDA set a PDUFA target action date of May 16, 2024FORT LEE, N.J., July 17, 2023...
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease Small molecule varoglutamstat,...
BridgeBio to Host Investor Call to Share Topline 30-month Results from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy on July 17, 2023
PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused...